Hasil Pencarian - Marcelo R. Bacci

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial

    Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial oleh Garyfallia Poulakou, Maxime Barakat, Robert J. Israel, Marcelo R. Bacci, Virazole Collaborator Group for COVID‐19 Respiratory Distress

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes

    Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes oleh Marcelo R. Bacci, Ethel Z. Chehter, Ligia A. Azzalis, Beatriz Costa de Aguiar Alves, Fernando L.A. Fonseca

    Diterbitkan 2017-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    The importance of homocysteine levels in the prognosis of patients with chronic renal disease and in hemodialysis patients

    The importance of homocysteine levels in the prognosis of patients with chronic renal disease and in hemodialysis patients oleh Bruna M. Martella, Glaucia Raquel L. Veiga, Beatriz C. A. Alves, Ligia A. Azzalis, Virginia B. C. Junqueira, Flavia S. Gehrkei, Fernando Luiz A. Fonseca, Marcelo R. Bacci

    Diterbitkan 2018-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)

    Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study pro... oleh Pascal Urwyler, Panteleimon Charitos, Stephan Moser, Ingmar A. F. M. Heijnen, Marten Trendelenburg, Reto Thoma, Johannes Sumer, Adrián Camacho-Ortiz, Marcelo R. Bacci, Lars C. Huber, Melina Stüssi-Helbling, Werner C. Albrich, Parham Sendi, Michael Osthoff

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial

    Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial oleh Pascal Urwyler, Marina Leimbacher, Panteleimon Charitos, Stephan Moser, Ingmar A. F. M. Heijnen, Marten Trendelenburg, Marten Trendelenburg, Marten Trendelenburg, Reto Thoma, Johannes Sumer, Adrián Camacho-Ortiz, Marcelo R. Bacci, Lars C. Huber, Melina Stüssi-Helbling, Werner C. Albrich, Parham Sendi, Michael Osthoff, Michael Osthoff, Michael Osthoff

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Endothelial, renal and hepatic variables in wistar rats treated with Vancomycin

    Endothelial, renal and hepatic variables in wistar rats treated with Vancomycin oleh FELIPE R. BRUNIERA, FELIPE M. FERREIRA, LUIZ R.M. SAVIOLI, MARCELO R. BACCI, DAVID FEDER, EDIMAR C. PEREIRA, MAVILDE L.G. PEDREIRA, MARIA A.S. PETERLINI, FÁBIO F. PERAZZO, LIGIA A. AZZALIS, PAULO C.P. ROSA, VIRGINIA B.C. JUNQUEIRA, MONICA A. SATO, FERNANDO L.A. FONSECA

    Diterbitkan 2014-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: